Reproductive and Obstetric Complications Associated with Antiphospholipid Syndrome
International Health Sciences Review · 2025
DOI: 10.70164/ihsr.v1i3.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, 2025. Verfasst von Lígia Maria Oliveira de Souza und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies (APAs). It is frequently associated with thrombotic and obstetric complications in women of reproductive age. This article reviews the main reproductive and obstetric complications related to APS, including primary infertility, embryonic implantation failure, recurrent miscarriages, fetal loss, preeclampsia, intrauterine growth restriction, and preterm birth. It addresses the pathophysiological mechanisms involved, such as placental dysfunction, alterations in spiral artery remodeling, and inflammatory processes mediated by APAs and the complement system. We conclude that early recognition of this clinical entity is essential, given its catastrophic clinical repercussions, precisely to improve reproductive and obstetric outcomes associated with high mortality rates.
Zitieren
APA
Souza, L. M. O. D., Mariano, E., Vigilato, P. M., Santos, L. B., Xavier, C. C. S., & Dias, J. R. S. (2025). Reproductive and Obstetric Complications Associated with Antiphospholipid Syndrome. International Health Sciences Review. https://doi.org/10.70164/ihsr.v1i3.15
Vancouver
Souza LMOD, Mariano E, Vigilato PM, Santos LB, Xavier CCS, Dias JRS. Reproductive and Obstetric Complications Associated with Antiphospholipid Syndrome. International Health Sciences Review. 2025. doi:10.70164/ihsr.v1i3.15
BibTeX
@article{Souza2025,
author = {Souza, Lígia Maria Oliveira de and Mariano, Elton and Vigilato, Paloma Marcela and Santos, Leidiane Barbosa and Xavier, Carla Cristina Sousa and Dias, Jéssica Rinelle Soares},
title = {Reproductive and Obstetric Complications Associated with Antiphospholipid Syndrome},
journal = {International Health Sciences Review},
year = {2025},
doi = {10.70164/ihsr.v1i3.15}
}
EUVIMED